Changeflow GovPing Healthcare & Life Sciences KAO Corporation Dual Hydrogel Patent, Apr 21
Routine Notice Added Final

KAO Corporation Dual Hydrogel Patent, Apr 21

Favicon for changeflow.com USPTO Patent Grants - Pharma (A61K)
Published
Detected
Email

Summary

KAO Corporation has been granted US Patent 12605311B2 for a dual hydrogel structure comprising a continuous phase of a first hydrogel and a dispersed second hydrogel phase. The patent specifies a ratio of local minimum load after break to breaking load of 0.1 or more, covering 23 claims with inventors Saki Hamada and Shohei Toyota. The application was filed on February 5, 2021, under application number 18275832.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors USPTO Patent Grants - Pharma (A61K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 22 changes logged to date.

What changed

KAO Corporation has obtained US Patent 12605311B2 for a dual hydrogel structure. The invention comprises a continuous phase of a first hydrogel and a dispersed second hydrogel phase, with a specified mechanical property ratio of at least 0.1. The patent covers 23 claims and lists Saki Hamada and Shohei Toyota as inventors.

Pharmaceutical, cosmetic, and chemical companies developing hydrogel-based products should review this patent to assess potential freedom-to-operate concerns. Competitors in personal care, drug delivery, or biomedical applications using dual-phase hydrogel technology may need to evaluate licensing options or design-around strategies.

Archived snapshot

Apr 22, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Hydrogel structure

Grant US12605311B2 Kind: B2 Apr 21, 2026

Assignee

KAO CORPORATION

Inventors

Saki Hamada, Shohei Toyota

Abstract

A hydrogel structure (10) includes: a continuous phase (11) of a first hydrogel; and a dispersion phase (12) of a second hydrogel, the dispersion phase being dispersed in the continuous phase (11). A ratio of a local minimum value of a load after break to a breaking load (a local minimum value of a load after break/a breaking load) of the hydrogel structure (10) is 0.1 or more.

CPC Classifications

A61K 8/042 A61K 8/73 C08J 3/075 C08J 2305/12

Filing Date

2021-02-05

Application No.

18275832

Claims

23

View original document →

Get daily alerts for USPTO Patent Grants - Pharma (A61K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 21st, 2026
Instrument
Notice
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12605311B2

Who this affects

Applies to
Drug manufacturers Manufacturers Healthcare providers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent grant IP licensing
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Chemical Manufacturing

Get alerts for this source

We'll email you when USPTO Patent Grants - Pharma (A61K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!